Skip to content
Screener

Nuvation Bio NUVB Net margin

Net margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
18.9%+8.4pp
Pfizer logo
PfizerPFE
15.7%—
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
121.5%+103pp
Immunome logo
ImmunomeIMNM
-5,593.8%-11,284pp
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-10,773.5%-878,492pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-393.2%-663pp

Other financials

Income statement

See full
Revenue$31.7M+556%
Gross profit$9.8M+1,340%
Operating income-$51.0M+19.7%
Net income-$62.8M-6.5%
EPS (diluted)-$0.18-5.9%

Balance sheet

See full
Cash & equivalents$258.6M+4.3%
Total debt$9.5M-83.5%
Total equity$253.9M-31.9%
Total assets$744.5M+15.0%

Cash flow

See full
Operating cash flow-$43.0M+10.8%
CapEx$254.0K+40.3%
Free cash flow-$43.2M+10.6%

Valuation

See full
Market cap$2.15B+168%
Enterprise value$1.9B+211%
P/S12.6×-43.1×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-81%-39.4pp
FCF margin-75.7%-36.6pp

Returns & leverage

See full
Return on equity-47.8%-9.8pp
Debt / equity0×-0.1×
Current ratio8.4×-1.0×

Where this comes from

Calculated from Nuvation Bio’s reported figures.

net income/total revenue=-88.2%

Based on trailing twelve months.

The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 6:55 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336646

FAQ

What is Nuvation Bio's net margin?
Nuvation Bio (NUVB) reported net margin of -88.2% in Q2 2026.
How has Nuvation Bio's net margin changed year-over-year?
Nuvation Bio's net margin increased by 93.8% year-over-year, from -1,413.4% to -88.2%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about Nuvation Bio's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude